Director sells 8,203 shares under 10b5-1
Andrew Dignan reported sales of Common Stock under a 10b5-1 plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Andrew Dignan reported sales of Common Stock under a 10b5-1 plan. The filing lists two dispositions: 5,645 shares sold on 06/04/2026 for $139,656.17 and 2,558 shares sold on 06/03/2026 for $63,463.98. The securities include Restricted Stock Units dated 03/04/2024.
Insights
Insider completed routine sales under a 10b5-1 arrangement.
The filing shows two reported dispositions by Andrew Dignan executed on 06/03/2026 and 06/04/2026, totaling 8,203 shares and proceeds of $203,120.15. The transactions are labeled as 10b5-1 Sales, indicating they were effected under a prearranged trading plan.
Cash‑flow treatment and remaining holdings are not detailed in the excerpt; subsequent filings may provide position totals or additional context.
Key Figures
Key Terms
10b5-1 regulatory
Restricted Stock Units financial
Common financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What sales did Andrew Dignan report for FIVN?
Were the transactions executed under a trading plan for FIVN?
What type of securities were involved in the FIVN filing?
Does the filing state remaining holdings after these sales for FIVN?
AI-generated analysis. How Rhea-AI works. Not financial advice.